# Fairy Life Sciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fairy-life-sciences

- Industry: Medical Devices & Equipment
- Headquarters: Wuhan, China
- Total disclosed funding: $14M
- Latest round: Angel (Aug 11, 2025)
- Investors on record: 3

## About

Founded in 2025 and based in Wuhan, China, Fairy Life Sciences engages in the research, development, and promotion of related medical products and technologies, focusing on LASE (Linear Array Spot Excitation) spectral imaging flow cytometer. In August 2025, Fairy Life Sciences raised approximately CNY 100 million in angel funding co-led by new investors Mingxi Capital and Legend Capital, with participation from new investor Hubei Science Technology Investment Group. Fairy Life Sciences offers self-developed LASE spectral imaging technology with application in medical research. The company generate revenue from offering LASE technology and devices. The new funding will be used to develop the company's innovative LASE (Linear Array Spot Excitation) spectral imaging flow cytometer.

## Funding rounds

- Angel, Aug 11, 2025, $14M — Legend Capital, Hubei Science Technology Investment Group, Mingxi Capital

## Investors

- Legend Capital — Angel
- Hubei Science Technology Investment Group — Angel
- Mingxi Capital (https://capitalatlas.ai/funds/mingxi-capital) — Angel